Target Identification | Prioritization
Pharmaceutical companies use Molecular Connections’ custom curation services to identify novel drug targets and also to prioritize targets for further research. Safety data around the targets is also mined for further investigation.
Target Identification | Prioritization discovery is crucial for a successful drug development campaign. Understanding the biological basis of a disease is crucial to discover potential molecular targets for therapeutic intervention. Scientific literature available in the public domain serves as an excellent resource to extract information on possible drug targets. However, growing volume of the published literature has made it difficult for researchers to extract relevant information and be up-to-date with the developments.
Molecular Connections’ highly skilled domain experts extract molecular target related information such as target safety, expression profiles (in vitro and in vivo), disease association, target interactome from vast literature sources with higher efficiency and accuracy. The curated data can be provided in client desired format (network data formats are also supported) facilitating easier analysis and further prediction.
Select Case Studies
- Molecular Connections’ custom-curation services team assisted a top pharmaceutical company to step up the target discovery/ prioritization process by mining information on various biomedical entities of the specific targets and integrating the information onto the customers internal database.
- Target safety data was manually curated from scientific literature for a list of molecular targets and drugs provided by the pharmaceutical company in order to prioritize targets for further research.